143 related articles for article (PubMed ID: 29362563)
21. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
[TBL] [Abstract][Full Text] [Related]
22. Dopamine enhances somatostatin receptor-mediated inhibition of adenylate cyclase in rat striatum and hippocampus.
Rodríguez-Sánchez MN; Puebla L; López-Sañudo S; Rodríguez-Martín E; Martín-Espinosa A; Rodríguez-Pena MS; Juarranz MG; Arilla E
J Neurosci Res; 1997 May; 48(3):238-48. PubMed ID: 9160246
[TBL] [Abstract][Full Text] [Related]
23. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.
Kobayashi S; Ogren SO; Hoffer BJ; Olson L
Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169
[TBL] [Abstract][Full Text] [Related]
24. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
25. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons.
Beckstead RM
Neuroscience; 1988 Dec; 27(3):851-63. PubMed ID: 3150855
[TBL] [Abstract][Full Text] [Related]
26. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area.
Vezina P
J Neurosci; 1996 Apr; 16(7):2411-20. PubMed ID: 8601820
[TBL] [Abstract][Full Text] [Related]
27. In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.
Hjorth S; Carlsson A
J Neural Transm; 1988; 72(2):83-97. PubMed ID: 2968439
[TBL] [Abstract][Full Text] [Related]
28. D1 dopamine receptor blockade prevents the facilitation of amphetamine self-administration induced by prior exposure to the drug.
Pierre PJ; Vezina P
Psychopharmacology (Berl); 1998 Jul; 138(2):159-66. PubMed ID: 9718285
[TBL] [Abstract][Full Text] [Related]
29. Dopaminergic toxicity associated with oral exposure to the herbicide atrazine in juvenile male C57BL/6 mice.
Coban A; Filipov NM
J Neurochem; 2007 Mar; 100(5):1177-87. PubMed ID: 17217422
[TBL] [Abstract][Full Text] [Related]
30. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
[TBL] [Abstract][Full Text] [Related]
31. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats.
Berger K; Przedborski S; Cadet JL
Brain Res Bull; 1991 Feb; 26(2):301-7. PubMed ID: 1826461
[TBL] [Abstract][Full Text] [Related]
32. Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.
Tsukada H; Kreuter J; Maggos CE; Unterwald EM; Kakiuchi T; Nishiyama S; Futatsubashi M; Kreek MJ
J Neurosci; 1996 Dec; 16(23):7670-7. PubMed ID: 8922423
[TBL] [Abstract][Full Text] [Related]
33. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
34. Effects of chronic alcohol and repeated deprivations on dopamine D1 and D2 receptor levels in the extended amygdala of inbred alcohol-preferring rats.
Sari Y; Bell RL; Zhou FC
Alcohol Clin Exp Res; 2006 Jan; 30(1):46-56. PubMed ID: 16433731
[TBL] [Abstract][Full Text] [Related]
35. Use of positron emission tomography to measure the effects of nalmefene on D1 and D2 dopamine receptors in rat brain.
Unterwald EM; Tsukada H; Kakiuchi T; Kosugi T; Nishiyama S; Kreek MJ
Brain Res; 1997 Nov; 775(1-2):183-8. PubMed ID: 9439841
[TBL] [Abstract][Full Text] [Related]
36. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T
Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295
[TBL] [Abstract][Full Text] [Related]
37. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine.
Ben-Shahar O; Keeley P; Cook M; Brake W; Joyce M; Nyffeler M; Heston R; Ettenberg A
Brain Res; 2007 Feb; 1131(1):220-8. PubMed ID: 17161392
[TBL] [Abstract][Full Text] [Related]
38. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
Beckstead RM; Wooten GF; Trugman JM
J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
[TBL] [Abstract][Full Text] [Related]
39. D1/D2 dopamine receptor interaction in membrane abolished by 6-hydroxydopamine lesion.
Guo X; Zou LL; Jin GZ
Life Sci; 1998; 63(1):PL7-12. PubMed ID: 9667768
[TBL] [Abstract][Full Text] [Related]
40. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]